Normal View Dyslexic View

Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.

1 January 2022
Randomized clinical trials Upper GI
Barham KAD, Maselli DB, Rapaka B, Lavin T, Noar M, Hussan H et al.
Lancet 2021; 398: 1965-1973.

This multicentre study included 288 patients randomized to lifestyle intervention with additional intragastric balloon therapy. After 32 weeks, mean total bodyweight loss was greater in the balloon group: 15 versus 3.3 per cent (P,0.0001). Some 17 per cent of balloons were removed for intolerance.

Comment: This is now an old technology that has never really taken off.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Info
Copied!